$CYCC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cyclacel Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cyclacel Pharmaceuticals, Inc.. Get notifications about new insider transactions in Cyclacel Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2020 | CYCC | Cyclacel Pharmaceu ... | SCHWARTZ BRIAN | Director | Option Exercise | A | 4.13 | 5,200 | 21,476 | 5,200 | |
Dec 21 2020 | CYCC | Cyclacel Pharmaceu ... | SCHWARTZ BRIAN | Director | Option Exercise | A | 4.13 | 5,200 | 21,476 | 5,200 | |
Dec 15 2020 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | See Remarks | Option Exercise | A | 4.32 | 120,000 | 518,400 | 120,000 | |
Dec 15 2020 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 4.32 | 175,000 | 756,000 | 175,000 | |
Nov 12 2020 | CYCC | Cyclacel Pharmaceu ... | Walker Karin L | Director | Option Exercise | A | 3.33 | 5,200 | 17,316 | 5,200 | |
Oct 28 2020 | CYCC | Cyclacel Pharmaceu ... | Kirschbaum Mark | Chief Medical Offic ... | Option Exercise | A | 3.77 | 120,000 | 452,400 | 120,000 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | Spiegel Robert J. | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.56 | 10,182 | 15,884 | 10,182 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.74 | 11,067 | 19,257 | 11,067 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.56 | 10,182 | 15,884 | 10,182 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.56 | 15,625 | 24,375 | 15,625 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.74 | 11,067 | 19,257 | 11,067 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.74 | 15,625 | 27,188 | 15,625 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.56 | 11,980 | 18,689 | 11,980 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.56 | 15,625 | 24,375 | 15,625 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.74 | 13,022 | 22,658 | 13,022 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.74 | 15,625 | 27,188 | 15,625 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.56 | 11,980 | 18,689 | 11,980 | |
Dec 09 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.74 | 13,022 | 22,658 | 13,022 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Spiegel Robert J. | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Spiegel Robert J. | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
May 31 2019 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.56 | 11,980 | 18,689 | 11,980 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 1.74 | 13,021 | 22,657 | 13,021 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E. VP, Fin, CFO and ... | Option Exercise | A | 0.71 | 270,079 | 191,756 | 270,079 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.56 | 10,183 | 15,885 | 10,183 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.74 | 11,068 | 19,258 | 11,068 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 0.71 | 284,592 | 202,060 | 284,592 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.56 | 14,375 | 22,425 | 14,375 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 1.74 | 15,625 | 27,188 | 15,625 | |
Jan 07 2019 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and CEO | Option Exercise | A | 0.71 | 508,198 | 360,821 | 508,198 | |
Sep 10 2018 | CYCC | Cyclacel Pharmaceu ... | Spiegel Robert J. | Director | Option Exercise | A | 1.43 | 8,576 | 12,264 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
Jul 21 2017 | CYCC | Cyclacel Pharmaceu ... | Eastern Capital LTD | 10% Owner | Option Exercise | P | 2.00 | 1 | 2 | 1 | |
Jul 21 2017 | CYCC | Cyclacel Pharmaceu ... | Eastern Capital LTD | 10% Owner | Buy | P | 2.00 | 850,000 | 1,700,000 | 2,167,261 | 1.3 M to 2.2 M (+64.53 %) |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Jun 01 2017 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 4.38 | 2,000 | 8,760 | 2,000 | |
Feb 27 2017 | CYCC | Cyclacel Pharmaceu ... | TANG KEVIN C | 10% Owner | Buy | P | 4.34 | 134,200 | 582,079 | 559,900 | 425.7 K to 559.9 K (+31.52 %) |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
May 31 2016 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 0.43 | 15,000 | 6,435 | 15,000 | |
Dec 09 2015 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 0.59 | 229,858 | 135,386 | 229,858 | |
Dec 09 2015 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E.V.P., Fin, C.F.O. ... | Option Exercise | A | 0.59 | 260,432 | 153,394 | 260,432 | |
Dec 09 2015 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Option Exercise | A | 0.59 | 437,569 | 257,728 | 437,569 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
May 26 2015 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 0.80 | 15,000 | 12,000 | 15,000 | |
Feb 20 2015 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Option Exercise | A | 0.86 | 81,742 | 70,298 | 81,742 | |
Feb 20 2015 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E.V.P.,Finance,C.F. ... | Option Exercise | A | 0.86 | 53,095 | 45,662 | 53,095 | |
Feb 20 2015 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 0.86 | 42,940 | 36,928 | 42,940 | |
Nov 20 2014 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Buy | P | 3.00 | 3,100 | 9,300 | 3,100 | 0 to 3.1 K |
Sep 11 2014 | CYCC | Cyclacel Pharmaceu ... | BARKER SAM L | Director | Option Exercise | A | 3.26 | 9,000 | 29,340 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
May 23 2014 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 3.09 | 9,000 | 27,810 | 9,000 | |
Dec 10 2013 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 4.61 | 65,000 | 299,650 | 65,000 | |
Dec 10 2013 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | E.V.P.,Finance,C.F. ... | Option Exercise | A | 4.61 | 70,000 | 322,700 | 70,000 | |
Dec 10 2013 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Option Exercise | A | 4.61 | 105,000 | 484,050 | 105,000 | |
May 24 2013 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 3.00 | 100,000 | 300,000 | 241,416 | 141.4 K to 241.4 K (+70.71 %) |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 2.99 | 3,571 | 10,677 | 3,571 | |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 2.99 | 3,571 | 10,677 | 3,571 | |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 2.99 | 5,000 | 14,950 | 5,000 | |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 2.99 | 3,571 | 10,677 | 3,571 | |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 2.99 | 7,142 | 21,355 | 7,142 | |
May 23 2013 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 2.99 | 7,142 | 21,355 | 7,142 | |
May 22 2013 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 3.00 | 100,000 | 300,000 | 268,292 | 168.3 K to 268.3 K (+59.42 %) |
May 22 2013 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Buy | P | 3.00 | 33,333 | 99,999 | 33,333 | 0 to 33.3 K |
May 22 2013 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Buy | P | 3.08 | 4,615 | 14,214 | 70,096 | 65.5 K to 70.1 K (+7.05 %) |
May 22 2013 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Buy | P | 3.00 | 8,333 | 24,999 | 65,481 | 57.1 K to 65.5 K (+14.58 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 157,501 | 137.5 K to 157.5 K (+14.55 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & CEO | Grant | A | 0.00 | 10,791 | 0 | 168,292 | 157.5 K to 168.3 K (+6.85 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Grant | A | 0.00 | 20,000 | 0 | 55,452 | 35.5 K to 55.5 K (+56.41 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Grant | A | 0.00 | 5,668 | 0 | 61,120 | 55.5 K to 61.1 K (+10.22 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Grant | A | 0.00 | 20,000 | 0 | 68,721 | 48.7 K to 68.7 K (+41.05 %) |
Jan 29 2013 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Grant | A | 0.00 | 6,712 | 0 | 75,433 | 68.7 K to 75.4 K (+9.77 %) |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | Sems Lloyd | Director | Option Exercise | A | 0.47 | 25,000 | 11,750 | 25,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 50,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 50,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 0.47 | 25,000 | 11,750 | 25,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | Hradsky Gregory T. | Director | Option Exercise | A | 0.47 | 25,000 | 11,750 | 25,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 0.47 | 25,000 | 11,750 | 25,000 | |
May 24 2012 | CYCC | Cyclacel Pharmaceu ... | SPIEGELMAN DANIEL K | Director | Option Exercise | A | 0.47 | 35,000 | 16,450 | 35,000 | |
Dec 27 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Option Exercise | M | 0.44 | 75,000 | 33,000 | 0 | |
Dec 27 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | M | 0.44 | 75,000 | 33,000 | 730,614 | 655.6 K to 730.6 K (+11.44 %) |
Dec 27 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 0.50 | 15,902 | 7,871 | 746,516 | 730.6 K to 746.5 K (+2.18 %) |
Dec 08 2011 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Grant | A | 0.00 | 60,000 | 0 | 133,168 | 73.2 K to 133.2 K (+82.00 %) |
Dec 08 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Grant | A | 0.00 | 75,000 | 0 | 655,614 | 580.6 K to 655.6 K (+12.92 %) |
Dec 08 2011 | CYCC | Cyclacel Pharmaceu ... | Sosnowski Robert Edward | VP, Marketing & Sal ... | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |
Dec 08 2011 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Grant | A | 0.00 | 75,000 | 0 | 263,054 | 188.1 K to 263.1 K (+39.88 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and C.E.O ... | Buy | P | 3.06 | 1,200 | 3,670 | 1,600 | 400 to 1.6 K (+300.00 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and C.E.O ... | Buy | P | 0.51 | 24,100 | 12,171 | 608,530 | 584.4 K to 608.5 K (+4.12 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President and C.E.O ... | Buy | P | 0.59 | 5,000 | 2,965 | 584,430 | 579.4 K to 584.4 K (+0.86 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.51 | 650,000 | 332,930 | 2,806,900 | 3.5 M to 2.8 M (-18.80 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.60 | 500,000 | 302,350 | 3,456,900 | 4 M to 3.5 M (-12.64 %) |
Sep 26 2011 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Buy | P | 0.50 | 12,000 | 6,000 | 188,054 | 176.1 K to 188.1 K (+6.82 %) |
Sep 14 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 3.23 | 400 | 1,291 | 400 | 0 to 400 |
Sep 14 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 0.67 | 12,000 | 8,052 | 579,430 | 567.4 K to 579.4 K (+2.11 %) |
Aug 24 2011 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Buy | P | 0.73 | 9,232 | 6,721 | 567,430 | 558.2 K to 567.4 K (+1.65 %) |
Aug 03 2011 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Option Exercise | J | 1.67 | 2,053,450 | 3,429,262 | 0 | |
May 26 2011 | CYCC | Cyclacel Pharmaceu ... | UPRICHARD DAVID C | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
May 26 2011 | CYCC | Cyclacel Pharmaceu ... | Bacopoulos Nicholas G | Director | Option Exercise | A | 1.53 | 25,000 | 38,250 | 25,000 | |
May 26 2011 | CYCC | Cyclacel Pharmaceu ... | Banham John Michael Middlecott | Director | Option Exercise | A | 1.53 | 25,000 | 38,250 | 25,000 | |
May 26 2011 | CYCC | Cyclacel Pharmaceu ... | SPIEGELMAN DANIEL K | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
May 26 2011 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
May 17 2011 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.80 | 50,000 | 90,000 | 3,956,900 | 4 M to 4 M (-1.25 %) |
May 17 2011 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.73 | 100,000 | 173,200 | 4,006,900 | 4.1 M to 4 M (-2.43 %) |
Dec 14 2010 | CYCC | Cyclacel Pharmaceu ... | Rombotis Spiro George | President & C.E.O. | Option Exercise | A | 1.59 | 75,000 | 119,250 | 75,000 | |
Dec 14 2010 | CYCC | Cyclacel Pharmaceu ... | Sosnowski Robert Edward | VP, Marketing & Sal ... | Option Exercise | A | 1.59 | 40,000 | 63,600 | 40,000 | |
Dec 14 2010 | CYCC | Cyclacel Pharmaceu ... | McBarron Paul | EVP, Finance, CFO, ... | Option Exercise | A | 1.59 | 75,000 | 119,250 | 75,000 | |
Dec 14 2010 | CYCC | Cyclacel Pharmaceu ... | Chiao Judy | V.P., Clin. Dev. & ... | Option Exercise | A | 1.59 | 62,500 | 99,375 | 62,500 | |
Dec 02 2010 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.90 | 142,000 | 269,871 | 4,106,900 | 4.2 M to 4.1 M (-3.34 %) |
Nov 30 2010 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.90 | 58,000 | 110,310 | 4,248,900 | 4.3 M to 4.2 M (-1.35 %) |
Oct 13 2010 | CYCC | Cyclacel Pharmaceu ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.67 | 183,982 | 307,728 | 4,306,900 | 4.5 M to 4.3 M (-4.10 %) |